Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Firsocostat

Firsocostat
Firsocostat (GS-0976) is an inhibitor of acetyl-CoA carboxylase (ACC) dimerization that inhibits human ACC1 and ACC2 activity (IC50s of 2.1 and 6.1 nM, respectively)
Catalog No. T7184Cas No. 1434635-54-7
Select Batch
Purity:98.46%
Contact us for more batch information

Resource Download

Firsocostat

Purity: 98.46%
Catalog No. T7184Alias NDI-010976, ND-630, GS-0976Cas No. 1434635-54-7

Firsocostat (GS-0976) is an inhibitor of acetyl-CoA carboxylase (ACC) dimerization that inhibits human ACC1 and ACC2 activity (IC50s of 2.1 and 6.1 nM, respectively)
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$88In Stock
2 mg$129In Stock
5 mg$222In Stock
10 mg$372In Stock
25 mg$537In Stock
50 mg$690In Stock
100 mg$955In Stock
500 mg$1,890In Stock
1 mL x 10 mM (in DMSO)$279In Stock
Bulk & Custom
Add to Cart

Related Compound Libraries of "Firsocostat"

Product Introduction

Bioactivity
Description
Firsocostat (GS-0976) is an inhibitor of acetyl-CoA carboxylase (ACC) dimerization that inhibits human ACC1 and ACC2 activity (IC50s of 2.1 and 6.1 nM, respectively)
Targets&IC50
ACC1:2.1 nM , ACC2:6.1 nM
In vitro
Firsocostat inhibited hACC1 with an IC50 of 2.1 ± 0.2 nM and hACC2 with an IC50 of 6.1 ± 0.8 nM .Inhibition was reversible and highly specific for ACC, as evidenced by the absence of an effect of Firsocostat on the activity of 101 enzymes, receptors, growth factors, transporters, and ion channels of the Ricerca DrugMatrix Panel at 10 μM .In addition, because the ACC dimerization site is not conserved among the mammalian carboxylases , Firsocostat lacks the ability to inhibit any of these mechanistically related enzymes and therefore exhibits absolute specificity for ACC inhibition relative to other mammalian carboxylases.
In vivo
ND-630 reduces hepatic steatosis in a rat model of diet-induced obesity and in Zucker diabetic rats. It also improves insulin secretion stimulated by glucose and reduces hemoglobin A1c levels by 0.9% in Zucker diabetic rats.
AliasNDI-010976, ND-630, GS-0976
Chemical Properties
Molecular Weight569.63
FormulaC28H31N3O8S
Cas No.1434635-54-7
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 60 mg/mL (105.33 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.7555 mL8.7776 mL17.5553 mL87.7763 mL
5 mM0.3511 mL1.7555 mL3.5111 mL17.5553 mL
10 mM0.1756 mL0.8778 mL1.7555 mL8.7776 mL
20 mM0.0878 mL0.4389 mL0.8778 mL4.3888 mL
50 mM0.0351 mL0.1756 mL0.3511 mL1.7555 mL
100 mM0.0176 mL0.0878 mL0.1756 mL0.8778 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Firsocostat | purchase Firsocostat | Firsocostat cost | order Firsocostat | Firsocostat chemical structure | Firsocostat in vivo | Firsocostat in vitro | Firsocostat formula | Firsocostat molecular weight